NCT05531734 MONITORING OF ATTENTION ACCORDING TO FATIGUE IN THE HEALTHY SUBJECT
| NCT ID | NCT05531734 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | FATIGUE |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-03-22 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-03-22 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To develop an easy-to-use measurement tool for monitoring fatigue and alertness, particularly in sleep-deprived subjects.
Eligibility Criteria
Inclusion Criteria: * Healthy volunteers. * Male, female. * Medical residents. * Aged between 24 and 34 years. * Doing emergency, intensive care or "inside" shifts. * Working in a health institution. * No history of epilepsy. * No background treatment that could have an impact on the EEG (electroencephalogram) data (type: benzodiazepines, anti-epileptics). * No significant change in background treatment during the study, if any. * Affiliation to the social security system. * Informed volunteer who has signed a consent form. Exclusion Criteria: \-
Contact & Investigator
Jean BERGOUNIOUX, MD, PhD
PRINCIPAL INVESTIGATOR
Pediatric Intensive Care Unit, Raymond Poincaré Hospital, APHP
Frequently Asked Questions
Who can join the NCT05531734 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying FATIGUE. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05531734 currently recruiting?
Yes, NCT05531734 is actively recruiting participants. Contact the research team at jean.bergounioux@gmail.com for enrollment information.
Where is the NCT05531734 trial being conducted?
This trial is being conducted at Garches, France.
Who is sponsoring the NCT05531734 clinical trial?
NCT05531734 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Jean BERGOUNIOUX, MD, PhD at Pediatric Intensive Care Unit, Raymond Poincaré Hospital, APHP. The trial plans to enroll 30 participants.